Trademark Overview
On Friday, June 26, 2026, a trademark application was filed for EPOCH EPIGENETICS with the United States Patent and Trademark Office. The USPTO has given the EPOCH EPIGENETICS trademark a serial number of 99908001. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 26, 2026. This trademark is owned by EPOCH Epigenetics, Inc.. The EPOCH EPIGENETICS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical research; Scientific research; Genetic testing for scientific research purposes; Medical and scientific research in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive disease, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical and scientific research in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Research laboratory analysis services in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Blood testing for scien...
Medical screening; Medical testing services; Genetic testing for medical purposes; Medical screening services in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive disease, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical testing for diagnostic or treatment purposes in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening services in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive dis...
